KRAS and carcinoma: Tetteh et al. [130] developed an inducible colon-specific cre enzyme mouse line for proximal tumors development with APC/KRAS mutation and aggressive carcinomas with some invasion into lymph nodes also developed upon a combined induction of oncogenic mutations of APC, Kras, p53, and SMAD4 in quadruple-mutant mice.